Skip to main content

A 6-week Randomized, Multicenter, Double-blind, Parallel, Fixed-dose Study of MG01CI (Metadoxine Immediate-release/Slow-release, Bilayer Caplet) 1400 mg Compared with Placebo in Adults with Attention Deficit/Hyperactivity Disorder (ADHD)

Clinical Trial Grant
Duke Scholars

Administered By

Psychiatry & Behavioral Sciences

Awarded By

Alcobra Ltd.

Start Date

April 1, 2014

End Date

March 31, 2015
 

Administered By

Psychiatry & Behavioral Sciences

Awarded By

Alcobra Ltd.

Start Date

April 1, 2014

End Date

March 31, 2015